Evaluation of two antibodies against double-stranded DNA assays in discriminating between active and non-active systemic lupus erythematosus: Correlation between the cut-off and the specificity

Pathologie Biologie

Volumn 60, Issue 6, 2012, Pages 387-391

  Martin, J ^a   Durant, C ^b   Rimbert, M ^a   Hemont, C ^a   Hamidou, M ^a   Audrain, M ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Antibodies against double stranded DNA; Laboratory tests; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PROCESS OPTIMIZATION; QUANTITATIVE ASSAY; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES; ANTIBODIES, ANTINUCLEAR; ANTIBODY AFFINITY; CHILD; DNA; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 84870392433     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.12.003     Document Type: Article

References (19)

1. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
2. Kavanaugh A.F., Solomon D.H. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002, 47:546-555. and the American College of Rheumatology ad hoc committee on immunologic testing guidelines.
3. Isenberg D., Smeenk R. Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now?. Lupus 2002, 11:797-800.
4. Jaekel H.P., Trabandt A., Grobe N., Werle E. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus 2006, 15:335-345.
5. Hochberg M. Updating the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725-1734.
6. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992, 35:630-640.
7. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939.
8. Isenberg D. Anti-dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus?. Lupus 2004, 13:881-885.
9. Ter Borg E.J., Horst G., Hummel E.J., Limburg P.C., Kallenberg C.G. Measurement of increases of anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long term, prospective study. Arthritis Rheum 1990, 33:634-643.
10. Rekvig O.P., Nossent J.C. Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus. A time for new paradigms?. Arthritis Rheum 2003, 48:300-312.
11. Riboldi P., Gerosa M., Moroni G., et al. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?. Autoimmunity 2005, 38:39-45.
12. Swaak A.J.G., Groenwold J., Aarden L.A., Statius Van Eps L.W., Feltkamp E.W. Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 1982, 41:388-395.
13. Ho A., Magder L.S., Barr S.G., Petri M. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum 2001, 44:2342-2349.
14. Barr S.G., Zonana-Nacach A., Magder L.S. Petri Ml. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999, 42:2682-2688.
15. Hale G.M., Highton J., Kalmakoff J., Palmer D.G. Changes in anti-DNA antibody affinity during exacerbations of systemic lupus erythematosus. Scand J Rheumatol 1985, 15:243-250.
16. Nossent J.C., Huysen V., Smeenk R.J.T., Swaak A.J.G. Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance. Ann Rheum Dis 1989, 48:677-682.
17. Lopez-Hoyos M., Cabeza R., Martinez-Taboada V.M., et al. Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus. Lupus 2005, 14:505-509.
18. Isenberg D.A., Shoenfeld Y., Walport M., et al. Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and in their relatives. Arthritis Rheum 1985, 28:999-1007.
19. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Rheum 2002, 47:429-433. American College of Rheumatology ad hoc committee on immunologic testing guidelines.